Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109775593 | 10977559 | 3 | F | 201410 | 20160912 | 20150402 | 20160914 | EXP | CA-ROCHE-1558750 | ROCHE | 58.87 | YR | F | Y | 0.00000 | 20160914 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109775593 | 10977559 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE: 18/FEB/2014, 30/JUN/2016 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
| 109775593 | 10977559 | 2 | SS | RITUXAN | RITUXIMAB | 1 | 103705 | ||||||||||||
| 109775593 | 10977559 | 3 | SS | RITUXAN | RITUXIMAB | 1 | 103705 | ||||||||||||
| 109775593 | 10977559 | 4 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | Y | 0 | 100 | MG | ||||||||
| 109775593 | 10977559 | 5 | SS | ACTONEL | RISEDRONATE SODIUM | 1 | Unknown | Y | 0 | ||||||||||
| 109775593 | 10977559 | 6 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 109775593 | 10977559 | 7 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG | |||||||||
| 109775593 | 10977559 | 8 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 0 | ||||||||||||
| 109775593 | 10977559 | 9 | C | ONE ALPHA | ALFACALCIDOL | 1 | 0 | ||||||||||||
| 109775593 | 10977559 | 10 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 109775593 | 10977559 | 11 | C | ASACOL | MESALAMINE | 1 | 0 | ||||||||||||
| 109775593 | 10977559 | 12 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
| 109775593 | 10977559 | 13 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 30 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109775593 | 10977559 | 1 | Cholangitis sclerosing |
| 109775593 | 10977559 | 2 | Colitis ulcerative |
| 109775593 | 10977559 | 3 | Hypersensitivity vasculitis |
| 109775593 | 10977559 | 4 | Product used for unknown indication |
| 109775593 | 10977559 | 5 | Product used for unknown indication |
| 109775593 | 10977559 | 6 | Premedication |
| 109775593 | 10977559 | 7 | Premedication |
| 109775593 | 10977559 | 12 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109775593 | 10977559 | HO |
| 109775593 | 10977559 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109775593 | 10977559 | Arthritis | |
| 109775593 | 10977559 | Infusion related reaction | |
| 109775593 | 10977559 | Off label use | |
| 109775593 | 10977559 | Osteoporosis | |
| 109775593 | 10977559 | Sepsis | |
| 109775593 | 10977559 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109775593 | 10977559 | 1 | 20130613 | 0 | ||
| 109775593 | 10977559 | 6 | 20130613 | 0 | ||
| 109775593 | 10977559 | 7 | 20130613 | 0 | ||
| 109775593 | 10977559 | 12 | 20130613 | 0 |